CLOMID 50MG 20TAB; clomiphen, hormonal agents .
ACTIVE-INGREDIENT OF CLOMID 50MG 20TAB
each tablet contains : 50 mg clomiphehence citrate .
INDICATION OF CLOMID 50MG 20TAB
treatment of ovulatory failure .
DOSAGE OF CLOMID 50MG 20TAB
Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet
Ask your pharmacist or doctor for help if you do not understand the instructions on the box .
The recommended dose is : –
adults : the recommended dose for the first course of clomid is 50 mg ( 1 tablet ) daily for 5 days . Therapy may be started at any time in the patient who has had no recent uterine bleeding . If progestin – induced bleeding is planned or if spontaneous uterine bleeding occurs before therapy , the regimen of 50 mg daily for 5 days should be started on or about the fifth day of the cycle . when ovulation occurs at this dosage , there is no advantage to increase the dose in subsequent cycles of treatment . if ovulation appears not to have occured after the first course of therapy , a second course of 100 mg daily ( two 50 mg tablets given as a single dose ) for 5 days should be given . this course may be started as early as 30 days should be given . this course may be started as early as 30 days after the previous one . increase of the dosage or duration of therapy beyond . 100 mg/day for 5 days should not be udertaken . the majority of patients who are going to respond will respond to the first course of therapy and three courses should constitute an adequate therapeutic trial . if ovulatory menses have not yet occured , the diagnosis should be re-evaluated . treatment beyond this is not recommended in the patient who does not exhibit evidence of ovulation . since the relative safety of long term cyclic therapy has not yet been conclusively demonstrated , and since the majority of patients will ovulate following 3 courses , long-term cyclic therapy is not recommended , i.e, beyond a total of about 6 cycles ( including 3 ovulatory cycles ) . special population : special care with lower dosage or duration of treatment course is paticularly recommended if unusual sensitivity to pituitary gonadotropin is suspected , such as in patients with polycystic ovary syndrome .
OVER-DOSAGE OF CLOMID 50MG 20TAB
human experience : toxic effects of acute overdosage of clomid have not been reported , but the number of overdose cases recorded is small . Management : in the event of overdose , appropiate supportive measures should be employed .
CONTRA-INDICATION OF CLOMID 50MG 20TAB
use in pregnancy : clomid should not administered during pregnancy . To avoid inadvertent clomid administration during early pregnancy , appropriate tests should be utilized during each treatment cycle to determine whether ovulation occurs . The patient should have a pregnancy test before the next course of clomid therapy . liver disease : clomid therapy is contraindicated in patients with liver disease or a history of liver dysfunction . hormone – dependennt tumors or abnormal uterine bleeding : clomid is contraindicated in patients with hormone- dependent tumors or in patients with abnormal uterine bleeding of undetermined origin . ovarian cyst : clomid should not be given in the presence of an ovarian cyst , except polycystic ovary , since further enlargement of the cyst may occur . patients should be evaluated for the presence of an ovarian cyst prior to each course of treatment .
STORAGE OF CLOMID 50MG 20TAB
Store at temperature not exceeding 30 °C, in a dry place .
PACK OF CLOMID 50MG 20TAB
boxes of 20 tablets each .
CLOMID 50MG 20TAB MANUFACTURED BY
GLOBAL NAPI PHARMACEUTICALS